PROGNOSIS IN CYSTIC-FIBROSIS TREATED WITH CONTINUOUS FLUCLOXACILLIN FROM THE NEONATAL-PERIOD

被引:89
作者
WEAVER, LT
GREEN, MR
NICHOLSON, K
MILLS, J
HEELEY, ME
KUZEMKO, JA
AUSTIN, S
GREGORY, GA
DUX, AEW
DAVIS, JA
机构
[1] PETERBOROUGH DIST GEN HOSP,PUBL HLTH LAB,PETERBOROUGH,ENGLAND
[2] ADDENBROOKES HOSP,DEPT CLIN BIOCHEM,CAMBRIDGE,CAMBS,ENGLAND
[3] ADDENBROOKES HOSP,DEPT PAEDIAT,CAMBRIDGE CB2 2QQ,ENGLAND
[4] ADDENBROOKES HOSP,DEPT RADIOL,CAMBRIDGE CB2 2QQ,ENGLAND
关键词
D O I
10.1136/adc.70.2.84
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
All newborn infants in East Anglia are screened for cystic fibrosis by blood immunoreactive trypsin assay at 7 days. Thirty eight infants with cystic fibrosis were randomised to treatment with either continuous oral flucloxacillin 250 mg/day (group P, n = 18) or with episodic antimicrobials as clinically indicated (group E, n = 20). Their progress was monitored from diagnosis to 24 months by a nurse coordinator who visited all infants regularly, at home and in hospital, to collect anthropometric, dietary, clinical, and microbiological data. Mean (range) age of confirmation of diagnosis was 5.7 weeks (1-14 weeks). There was no significant difference in birth weight, genotype, immunoreactive trypsin concentration, neonatal history, symptoms at diagnosis, pancreatic enzyme supplementation, or parental smoking history between the groups. Infants in group E had more frequent cough and a greater number of Staphylococcus aureus isolates than infants in group P. More infants of group E were admitted to hospital, had higher admission rates during the second year (19 v 5), for longer periods (6.4 v 2.2 days), despite receiving more than double the number of courses of antibiotics than group P infants (in addition to flucloxacillin). Continuous prophylactic flucloxacillin from early diagnosis of cystic fibrosis is associated with improved clinical progress during the first two years of life.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 24 条
[1]   EARLY BACTERIOLOGICAL, IMMUNOLOGICAL, AND CLINICAL COURSES OF YOUNG INFANTS WITH CYSTIC-FIBROSIS IDENTIFIED BY NEONATAL SCREENING [J].
ABMAN, SH ;
OGLE, JW ;
HARBECK, RJ ;
BUTLERSIMON, N ;
HAMMOND, KB ;
ACCURSO, FJ .
JOURNAL OF PEDIATRICS, 1991, 119 (02) :211-217
[2]   EFFECTS OF NEWBORN SCREENING OF CYSTIC-FIBROSIS ON REPORTED MATERNAL-BEHAVIOR [J].
BOLAND, C ;
THOMPSON, NL .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (11) :1240-1244
[3]   NEONATAL SCREENING FOR CYSTIC-FIBROSIS IN WALES AND THE WEST MIDLANDS - CLINICAL-ASSESSMENT AFTER 5 YEARS OF SCREENING [J].
CHATFIELD, S ;
OWEN, G ;
RYLEY, HC ;
WILLIAMS, J ;
ALFAHAM, M ;
GOODCHILD, MC ;
WELLER, P .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1991, 66 (01) :29-33
[4]   SYSTEMATIC EVALUATION OF CHEST RADIOGRAPH IN CYSTIC FIBROSIS [J].
CHRISPIN, AR ;
NORMAN, AP .
PEDIATRIC RADIOLOGY, 1974, 2 (02) :101-106
[5]   SURVIVAL AND CLINICAL OUTCOME IN PATIENTS WITH CYSTIC-FIBROSIS, WITH OR WITHOUT NEONATAL SCREENING [J].
DANKERTROELSE, JE ;
MEERMAN, GJT ;
MARTIJN, A ;
TENKATE, LP ;
KNOL, K .
JOURNAL OF PEDIATRICS, 1989, 114 (03) :362-367
[6]  
DAUPHINAIS RM, 1992, J CLIN IMMUNOASSAY, V15, P121
[7]  
DODGE JA, 1988, BRIT MED J, V297, P1599
[8]  
EASMON CSF, 1990, TOPLEY WILSONS PRINC, V2, P169
[9]   CYSTIC-FIBROSIS IDENTIFIED BY NEONATAL SCREENING - INCIDENCE, GENOTYPE, AND EARLY NATURAL-HISTORY [J].
GREEN, MR ;
WEAVER, LT ;
HEELEY, AF ;
NICHOLSON, K ;
KUZEMKO, JA ;
BARTON, DE ;
MCMAHON, R ;
PAYNE, SJ ;
AUSTIN, S ;
YATES, JRW ;
DAVIS, JA .
ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 68 (04) :464-467
[10]   EVALUATION OF GROWTH AND CHANGES IN BODY-COMPOSITION FOLLOWING NEONATAL DIAGNOSIS OF CYSTIC-FIBROSIS [J].
GREER, R ;
SHEPHERD, R ;
CLEGHORN, G ;
BOWLING, FG ;
HOLT, T .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1991, 13 (01) :52-58